British pharmaceutical giant GSK on Monday said chief executive Emma Walmsley will step down after nearly nine years at the helm, to be replaced by its chief commercial officer.
Luke Miels will take over from Walmsley on January 1, GSK said in a statement.
Earlier this month, GSK said it planned to invest $30 billion in the United States over the next five years, ahead of US President Donald Trump’s announcement last week that new tariffs will hit the pharmaceutical industry starting Wednesday.
READ ALSO: Lufthansa To Slash 4,000 Jobs By 2030
AFP
The post GSK’s CEO Emma Walmsley To Step Down appeared first on Channels Television.